Loading clinical trials...
Loading clinical trials...
An Open-label, Randomized, Multi-centre, Multiple Dose Trial to Investigate the Efficacy and Safety of Subcutaneous Injections of RO0503821 at Different Dosing Intervals in Patients With Chronic Renal Anemia Who Are Not on Renal Replacement Therapy
Conditions
Interventions
methoxy polyethylene glycol-epoetin beta [Mircera]
Locations
15
United States
Birmingham, Alabama, United States
San Diego, California, United States
Detroit, Michigan, United States
Detroit, Michigan, United States
Las Vegas, Nevada, United States
Portland, Oregon, United States
Start Date
March 1, 2002
Primary Completion Date
October 1, 2003
Completion Date
November 1, 2004
Last Updated
January 2, 2018
NCT05012111
NCT03520647
NCT05447442
NCT06287268
NCT04645199
NCT03050268
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions